Press release
Construction Chemicals
April 12, 2018

Interface & Performance attended MECS in Dubai

For the first time, the Interface & Performance Business Line attended the Middle East Coating Show from 19th of March to 21st of March 2018 in Dubai UAE.

The construction market has great potential in this region and the new product portfolio, a synergy of Interface & Performance plus former PMD products, perfectly suit customer needs.

Focus products and new products such as novel SITREN AirVoid® series for the construction industry have being exhibited at the booth of DIA 33, the exclusive distributor for the GCC region.

Over the 3 days we talked to more than 100 customers from different countries. We took advantage of having sales representatives joining us from Saudi-Arabia (Mr. Shihab Musliyarakath), from South-Africa (Mr. Rashid Jaffer), from Egypt (Mr. Hazem Habiba) and from Germany (Mr. Markus Roos, Team Leader Technical Service Construction Chemicals and Mr. Stefan Cassola, Business Director EMEA).

Presentations about Evonik Airvoid Management, new defoamers portfolio, water repellents and shrinkage reducers for Drymix mortars and Concrete Admixtures were given by Mr. Markus Roos.

DIA 33 has excellent relationship to key customers and offers complementary products to the construction industry. Our products are offered from Dia33 through local warehouse in UAE and KSA, in order to supply to local customers in short time.

Company information

Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2017, the enterprise generated sales of €14.4 billion and an operating profit (adjusted EBITDA) of €2.36 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

About Nutrition & Care

The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,500 employees, and generated sales of around
€4.3 billion in 2016.